Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.
about
MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.Clinical significance of mitofusin-2 and its signaling pathways in hepatocellular carcinoma.Lymphocyte-specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylationRoles and Signaling Pathways of Des-γ-Carboxyprothrombin in the Progression of Hepatocellular Carcinoma.Inhibition of HSP90 sensitizes a novel Raf/ERK dual inhibitor CY-9d in triple-negative breast cancer cells.Capsaicin and sorafenib combination treatment exerts synergistic anti‑hepatocellular carcinoma activity by suppressing EGFR and PI3K/Akt/mTOR signaling
P2860
Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Des-gamma-carboxy prothrombin ...... K/Akt/mTOR signaling pathways.
@en
type
label
Des-gamma-carboxy prothrombin ...... K/Akt/mTOR signaling pathways.
@en
prefLabel
Des-gamma-carboxy prothrombin ...... K/Akt/mTOR signaling pathways.
@en
P2093
P2860
P356
P1433
P1476
Des-gamma-carboxy prothrombin ...... K/Akt/mTOR signaling pathways.
@en
P2093
Shu-Qing Wang
Shu-Xiang Cui
Wen-Na Shi
Xian-Jun Qu
Xin-Feng Yu
Zhi-Yu Song
Zu-Hua Gao
P2860
P304
36767-36782
P356
10.18632/ONCOTARGET.9168
P407
P577
2016-05-04T00:00:00Z